Wells Fargo turned less bearish on BWXT today. The options market moved the other way.
That tension is the story. David Strauss lifted his rating to Equal-Weight from Underweight this morning — yet the put-call ratio hit 0.59, a 52-week high and 3.27 standard deviations above the 20-day mean. Both things happened on the same day.
Strauss acknowledged execution risks but pointed to a strong backlog as a reason to step back from his bearish stance. His price target dropped to $170 from $200 — still 15% below where it was when he initiated coverage in April.
That $170 target sits well below the analyst consensus mean of $232. Truist lowered its target to $202 earlier this month. BTIG reiterated Buy at $235. JP Morgan started coverage at Overweight with a $230 target in late July. The spread between the most bullish and most cautious targets is unusually wide — a sign that analysts are reading the same backlog story very differently.
The stock closed at $153.16 on Wednesday. That's down 12% over the past month and 5.6% over the past week.
The PCR spike is notable because it has happened twice. On August 17, it reached 0.57 — the previous 52-week high. On August 26, it climbed further to 0.59. Each time the ratio snapped back to baseline within a day. Each time it then pushed to a new extreme.
Tuesday's print of 0.59 is the highest in a year. The 20-day mean is 0.33. This isn't a gradual drift — it's a repeated, sharp demand for downside protection arriving in waves.
One piece of the picture moved in a different direction. Short interest fell 23% over the past week to 2.9% of free float — the lowest level in recent weeks. After spiking to 3.5% of float on August 18 (flagged in our previous report), short sellers have largely unwound that position. The borrow market remains very loose, with availability at 4,730% — roughly 47 shares available for every one currently borrowed.
The short score has also declined steadily, from 38.4 on August 18 to 33.8 today, consistent with the short interest retreat.
The bull case rests on nuclear propulsion contracts and a growing commercial nuclear pipeline. The bear case — articulated by Wells Fargo — centres on execution risk and tariff exposure. CEO Rex Geveden sold approximately $1.7 million in shares on August 12 across four transactions, a detail that remains in the recent-activity window.
First Trust Advisors added 684,471 shares in the most recent reporting period. Select Equity Group added 977,584. Both are notable accumulations against a backdrop of analyst uncertainty.
See the live data behind this article on ORTEX.
Open BWXT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
